Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor.

Détails

ID Serval
serval:BIB_36C26829EA64
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor.
Périodique
International Journal of Cancer
Auteur⸱e⸱s
Houimel M., Schneider P., Terskikh A., Mach J.P.
ISSN
0020-7136 (Print)
ISSN-L
0020-7136
Statut éditorial
Publié
Date de publication
2001
Volume
92
Numéro
5
Pages
748-755
Langue
anglais
Résumé
The HER-2/ErbB-2 oncoprotein is overexpressed in human breast and ovarian adenocarcinomas and is clearly associated with the malignant phenotype. Although no specific ligand for this receptor has been positively identified, ErbB-2 was shown to play a central role in a network of interactions with the related ErbB-1, ErbB-3 and ErbB-4 receptors. We have selected new peptides binding to ErbB-2 extracellular domain protein (ECD) by screening 2 newly developed constrained and unconstrained random hexapeptide phage libraries. Out of 37 phage clones, which bound specifically to ErbB-2 ECD, we found 6 constrained and 10 linear different hexapeptide sequences. Among the latter, 5 consensus motifs, all with a common methionine and a positively charged residue at positions 1 and 3, respectively, were identified. Furthermore, 3 representative hexapeptides were fused to a coiled-coil pentameric recombinant protein to form the so-called peptabodies recently developed in our laboratory. The 3 peptabodies bound specifically to the ErbB-2 ECD, as determined by enzyme-linked immunosorbent assay and BIAcore analysis and to tumor cells overexpressing ErbB-2, as shown by flow cytometry. Interestingly, one of the free selected linear peptides and all 3 peptabodies inhibited the proliferation of tumor cells overexpressing ErbB-2. In conclusion, a novel type of ErbB-2-specific ligand is described that might complement presently available monoclonal antibodies.
Mots-clé
Amino Acid Sequence, Antibodies, Monoclonal/therapeutic use, Antineoplastic Agents/metabolism, Female, Humans, Molecular Sequence Data, Oligopeptides/metabolism, Peptide Library, Receptor, erbB-2/metabolism, Tumor Cells, Cultured
Pubmed
Web of science
Open Access
Oui
Création de la notice
19/01/2008 17:31
Dernière modification de la notice
20/08/2019 13:24
Données d'usage